End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.25 CNY | +4.81% |
|
+2.50% | -35.13% |
16/05 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
25/04 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.13% | 573M | |
+1.87% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+75.10% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- 688319 Stock
- News Chengdu Olymvax Biopharmaceuticals Inc.
- Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine